Company Filing History:
Years Active: 2019-2025
Title: Ann Mongan: Innovator in Molecular Tagging and Immune Response Assessment
Introduction
Ann Mongan is a prominent inventor based in San Francisco, CA. She has made significant contributions to the fields of molecular tagging and immune response assessment. With a total of 4 patents to her name, her work has advanced the understanding and application of genetic technologies.
Latest Patents
Among her latest patents is a groundbreaking invention titled "Methods, systems, compositions, kits, apparatus and computer-readable media for molecular tagging." This invention relates to a multiplex molecular tagging procedure that utilizes a variety of tags appended to polynucleotides. These tags possess unique characteristics that allow for the identification and tracking of individual tagged molecules within a mixture. This technology is particularly useful for generating error-corrected sequencing data and detecting low-abundance target polynucleotides in nucleic acid samples.
Another notable patent is focused on "Compositions and methods for assessing immune response." This invention provides methods and compositions for evaluating gene expression related to tumor immune response profiles. It includes a target-specific primer panel that enables selective amplification of immune response target sequences, facilitating the detection of genetic variants and expression levels associated with immune responses.
Career Highlights
Ann Mongan is currently employed at Life Technologies Corporation, where she continues to innovate and contribute to advancements in biotechnology. Her work has been instrumental in developing methods that enhance the accuracy and efficiency of genetic analysis.
Collaborations
Throughout her career, Ann has collaborated with talented individuals such as Kelli Bramlett and Dumitru Brinza. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas.
Conclusion
Ann Mongan's contributions to molecular tagging and immune response assessment exemplify her dedication to advancing biotechnology. Her innovative patents and collaborative efforts continue to impact the field significantly.